Schmith, V D <br/><br/>
Alprazolam in end-stage renal disease. II. Pharmacodynamics.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 1992 
 - 533-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1038/clpt.1992.59  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alprazolam--blood<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Kidney Failure, Chronic--metabolism<br/>Male<br/>Motor Activity--drug effects<br/>Peritoneal Dialysis, Continuous Ambulatory<br/>Reference Values<br/>Renal Dialysis